Réaction #89903

ord-ed1e2bdb01f440f68adfb6a9c48e0b2e

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    ConcentrationThe solution was concentrated in vacuo
  2. 2
    Autrethe crude product was triturated with ether
  3. 3
    Filtrationfiltered
  4. 4
    Autredried under vacuum

Mode opératoire

TFA (4 mL) was added to 5-(2-[(3-phenyl)phenyl)-7-methoxy-6-(2-(4-methylpiperazin-1-yl)ethoxy)quinazolin-4-ylamino)-1H-indazole-1-carboxylate and the reaction was stirred at RT for 1.5 h. The solution was concentrated in vacuo and the crude product was triturated with ether and filtered, dried under vacuum to give 2-[(3-phenyl)phenyl)-N-(1H-indazol-5-yl)-7-methoxy-6-(2-(4-methylpiperazin-1-yl)ethoxy)quinazolin-4-amine (0.166 g, 0.283 mmole, 64% over two steps). MS 586.4 (M+1). HPLC retention time 5.06 mins.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09440961B2uspto-grants-2016_09